These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10693 related articles for article (PubMed ID: 10905502)

  • 1. Cytotoxic effects of 5-fluorocytosine on melanoma cells transduced with cytosine deaminase gene.
    Lü H; Wu D; Wan Y; Gu B; Wang J
    J Environ Pathol Toxicol Oncol; 2000; 19(1-2):9-12. PubMed ID: 10905502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation.
    Anello R; Cohen S; Atkinson G; Hall SJ
    J Urol; 2000 Dec; 164(6):2173-7. PubMed ID: 11061950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor.
    Mullen CA; Coale MM; Lowe R; Blaese RM
    Cancer Res; 1994 Mar; 54(6):1503-6. PubMed ID: 8137255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for human hepatocellular carcinoma with cytosine deaminase gene and prodrug flucytosine.
    Lü HZ; Wu DZ; Wan YL; Gu B; Gao HZ; Liang YQ; Wang JX
    Zhongguo Yao Li Xue Bao; 1999 May; 20(5):440-4. PubMed ID: 10678093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective augmentation of radiation effects by 5-fluorocytosine on murine B16(F10) melanoma cells transfected with cytosine deaminase gene.
    Szary J; Missol E; Tarnawski R; Szala S
    Cancer Gene Ther; 1997; 4(4):269-72. PubMed ID: 9253513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of prostate cancer cell lines to 5-fluorocytosine induced by adenoviral vector carrying a CD transcription unit.
    Yin L; Fu S; Wang X; Nanakorn T; Won J; Deisseroth A
    Chin Med J (Engl); 2001 Sep; 114(9):972-5. PubMed ID: 11780394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice.
    Cao X; Ju DW; Tao Q; Wang J; Wan T; Wang BM; Zhang W; Hamada H
    Gene Ther; 1998 Aug; 5(8):1130-6. PubMed ID: 10326037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic effect of 5-fluorocytosine on cytosine deaminase gene transduced Wilms' tumor xenograft in nude mice].
    Bi Y; Gao J; Xu D
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):113-5. PubMed ID: 11776635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil.
    Kuriyama S; Masui K; Sakamoto T; Nakatani T; Kikukawa M; Tsujinoue H; Mitoro A; Yamazaki M; Yoshiji H; Fukui H; Ikenaka K; Mullen CA; Tsujii T
    Anticancer Res; 1998; 18(5A):3399-406. PubMed ID: 9858915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and testing of gene therapy retroviral vector expressing bacterial cytosine deaminase gene.
    Hlavatý J; Hlubinová K; Altaner C
    Neoplasma; 1999; 46(5):267-76. PubMed ID: 10665841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.
    Huber BE; Austin EA; Good SS; Knick VC; Tibbels S; Richards CA
    Cancer Res; 1993 Oct; 53(19):4619-26. PubMed ID: 8402637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene.
    Khil MS; Kim JH; Mullen CA; Kim SH; Freytag SO
    Clin Cancer Res; 1996 Jan; 2(1):53-7. PubMed ID: 9816090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.
    Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T
    Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study on human pancreatic carcinoma treated by cytosine deaminase gene therapy].
    Zhang S; Yuan S
    Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):249-51. PubMed ID: 11798763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDR promoter can transcriptionally target cytosine deaminase suicide gene to cancer cells of nonendothelial origin.
    Szary J; Kalita K; Przybyszewska M; Dus D; Kieda C; Janik P; Szala S
    Anticancer Res; 2001; 21(5):3471-5. PubMed ID: 11848511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia.
    Fox ME; Lemmon MJ; Mauchline ML; Davis TO; Giaccia AJ; Minton NP; Brown JM
    Gene Ther; 1996 Feb; 3(2):173-8. PubMed ID: 8867865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme/prodrug gene therapy approach for breast cancer using a recombinant adenovirus expressing Escherichia coli cytosine deaminase.
    Li Z; Shanmugam N; Katayose D; Huber B; Srivastava S; Cowan K; Seth P
    Cancer Gene Ther; 1997; 4(2):113-7. PubMed ID: 9080120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of cytosine deaminase-5-fluorocytosine system. Enhancement of radiation cytotoxicity and bystander effect.
    Szary J; Missol E; Szala S
    Adv Exp Med Biol; 1998; 451():121-3. PubMed ID: 10026860
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma.
    Yi C; Huang Y; Guo ZY; Wang SR
    Acta Pharmacol Sin; 2005 May; 26(5):629-34. PubMed ID: 15842785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H
    Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 535.